12773448

Source:http://linkedlifedata.com/resource/pubmed/id/12773448

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0000768, umls-concept:C0002844, umls-concept:C0021641, umls-concept:C0028754, umls-concept:C0030705, umls-concept:C0032460, umls-concept:C0071097, umls-concept:C1280500
pubmed:issue	6
pubmed:dateCreated	2003-5-29
pubmed:abstractText	To investigate the effectiveness and safety of pioglitazone (45 mg/day) on clinical and endocrine-metabolic features of polycystic ovary syndrome (PCOS), we studied 18 obese PCOS patients, classified as normoinsulinaemic (N-PCOS, n = 6) and hyperinsulinaemic (H-PCOS, n = 12) according to their insulin secretion.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8701199
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/17-alpha-Hydroxyprogesterone, http://linkedlifedata.com/resource/pubmed/chemical/Androgens, http://linkedlifedata.com/resource/pubmed/chemical/Androstenedione, http://linkedlifedata.com/resource/pubmed/chemical/Follicle Stimulating Hormone, http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Insulin, http://linkedlifedata.com/resource/pubmed/chemical/Lipids, http://linkedlifedata.com/resource/pubmed/chemical/Luteinizing Hormone, http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones, http://linkedlifedata.com/resource/pubmed/chemical/pioglitazone
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0268-1161
pubmed:author	pubmed-author:CiampelliMM, pubmed-author:GiulianiMM, pubmed-author:GuidoMM, pubmed-author:LanzoneAA, pubmed-author:LeoniFF, pubmed-author:PerroMM, pubmed-author:RomualdiDD
pubmed:issnType	Print
pubmed:volume	18
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1210-8
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:12773448-17-alpha-Hydroxyprogesterone, pubmed-meshheading:12773448-Acne Vulgaris, pubmed-meshheading:12773448-Adolescent, pubmed-meshheading:12773448-Adult, pubmed-meshheading:12773448-Androgens, pubmed-meshheading:12773448-Androstenedione, pubmed-meshheading:12773448-Body Constitution, pubmed-meshheading:12773448-Body Mass Index, pubmed-meshheading:12773448-Female, pubmed-meshheading:12773448-Follicle Stimulating Hormone, pubmed-meshheading:12773448-Glucose Clamp Technique, pubmed-meshheading:12773448-Glucose Tolerance Test, pubmed-meshheading:12773448-Hirsutism, pubmed-meshheading:12773448-Humans, pubmed-meshheading:12773448-Hyperinsulinism, pubmed-meshheading:12773448-Hypoglycemic Agents, pubmed-meshheading:12773448-Insulin, pubmed-meshheading:12773448-Insulin Resistance, pubmed-meshheading:12773448-Lipids, pubmed-meshheading:12773448-Luteinizing Hormone, pubmed-meshheading:12773448-Obesity, pubmed-meshheading:12773448-Polycystic Ovary Syndrome, pubmed-meshheading:12773448-Thiazolidinediones
pubmed:year	2003
pubmed:articleTitle	Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome.
pubmed:affiliation	Department of Obstetrics and Gynecology, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Roma, Italy.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't